Emerging Stocks Down Under 12 April 2022: EBR Systems (ASX:EBR)
EBR Systems: Will it win investor's hearts?EBR Systems (ASX: EBR) is another heart disease focused medtech that listed on the ASX late last year. The company's WISE system works as a pacemaker, delivering pacing stimulation directly to the left ventricle of the heart thereby preventing heart failure. It is the size of a cooked grain of rise - 5% the size of a conventional pacemaker - and is currently in a pivotal trial, with FDA approval hoped for next year. This stock is one to watch but we would rather last week's subject Artrya (ASX: ATA) at this stage considering its earlier timeline for FDA approval. Click here to read the previous edition of Emerging Stocks Down Under published 5 April 2022 For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.
Please register or upgrade your plan to access this content.